Status:

COMPLETED

Phono- and Electrocardiogram Assisted Detection of Valvular Disease

Lead Sponsor:

University of California, San Francisco

Collaborating Sponsors:

Eko Devices, Inc.

Conditions:

Aortic Valve Stenosis

Mitral Regurgitation

Eligibility:

All Genders

18+ years

Brief Summary

The diagnosis of valvular heart disease (VHD), or its absence, invariably requires cardiac imaging. A familiar and inexpensive tool to assist in the diagnosis or exclusion of significant VHD could bot...

Detailed Description

Phono- and Electrocardiogram Assisted Detection of Valvular Disease (PEA-Valve Study) Specific aim(s) Aim 1: Can a machine learning algorithm derived from simultaneous phono- and electrocardiogram re...

Eligibility Criteria

Inclusion

  • Able to provide consent
  • Undergoing a complete echocardiogram

Exclusion

  • Refusal to participate

Key Trial Info

Start Date :

February 22 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 11 2019

Estimated Enrollment :

156 Patients enrolled

Trial Details

Trial ID

NCT03458806

Start Date

February 22 2018

End Date

November 11 2019

Last Update

July 2 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of California San Francisco

San Francisco, California, United States, 94143